<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="96429">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01849458</url>
  </required_header>
  <id_info>
    <org_study_id>Tornier 2013-1</org_study_id>
    <nct_id>NCT01849458</nct_id>
  </id_info>
  <brief_title>BioFiber Scaffold Post-Market Observational Study</brief_title>
  <official_title>BioFiber and BioFiber-CM Absorbable Biologic Scaffold for Soft Tissue Repair and Reinforcement Post-Market Surveillance Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tornier, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tornier, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to collect and report data from a consecutive series of patients
      implanted with these products as part of a post-market surveillance plan for CE Mark
      approval in the European Union.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>12 Months</time_frame>
    <description>The primary objective is to report the number of device associated adverse events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical Functional Outcome</measure>
    <time_frame>6 &amp; 12 Months</time_frame>
    <description>Evaluate clinical functional outcome Adjusted Constant-Murley Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-tears</measure>
    <time_frame>6 &amp; 12 Months</time_frame>
    <description>Assess re-tears of the repaired tendon using ultrasound imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Functional Outcome</measure>
    <time_frame>6 &amp; 12 Months</time_frame>
    <description>Evaluate clinical functional outcome WORC Index</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Full Thickness Rotator Cuff Tear</condition>
  <arm_group>
    <arm_group_label>BioFiber</arm_group_label>
    <description>Subjects implanted with BioFiber Scaffold or BioFiber-CM Scaffold</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BioFiber</intervention_name>
    <description>Subjects implanted with BioFiber or BioFiber-CM Scaffold</description>
    <arm_group_label>BioFiber</arm_group_label>
    <other_name>BioFiber Scaffold</other_name>
    <other_name>BioFiber-CM Scaffold</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Orthopedic referral clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years of age or older

               -  Patients with full thickness rotator cuff tears (confirmed at time of surgery)
                  that are eligible for rotator cuff repair.

               -  Patients willing and able to comply with the requirements of the study protocol
                  and provide informed consent.

        Exclusion Criteria:

          -  Patients with active or latent infection

          -  Patients with decreased vascularity

          -  Patients with pathological soft tissue conditions

          -  Patients with a known allergy or sensitivity to tetracycline hydrochloride or
             kanamycin sulfate

          -  Patients with a known allergy or sensitivity to bovine collagen (BioFiber-CM only)

          -  Participating in a concurrent study that has not been approved for concurrent
             enrollment by the Clinical Study Manager
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Brockmeier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Timothy Reish, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Insall Scott Kelly Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Collin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Gregoire, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Insall Scott Kelly Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Sports Medicine and Shoulder Surgery</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Gregoire</name>
      <address>
        <city>St. Gregoire</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <lastchanged_date>November 4, 2015</lastchanged_date>
  <firstreceived_date>May 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
